Waters Donatess Research Equipment to University at Buffalo to Combat HIV/AIDS
At a ceremony that coincided with the 20th anniversary of Los Angeles Laker Marvin ?Magic? Johnson?s public revelation that he had acquired Human Immunodeficiency Virus (HIV), the University at Buffalo?s School of Pharmacy and Pharmaceutical Sciences (Buffalo, New York) acknowledged Waters Corporation (Milford, Massachusetts) for its donation of an Acquity TQD System, a liquid chromatograph?mass spectrometer that will be used to build laboratory capacity and advance research into the treatment of HIV and Acquired Immune Deficiency Syndrome (AIDS)-related illnesses in sub-Saharan Africa.
At a ceremony that coincided with the 20th anniversary of Los Angeles Laker Marvin “Magic” Johnson’s public revelation that he had acquired Human Immunodeficiency Virus (HIV), the University at Buffalo’s School of Pharmacy and Pharmaceutical Sciences (Buffalo, New York) acknowledged Waters Corporation (Milford, Massachusetts) for its donation of an Acquity TQD System, a liquid chromatograph–mass spectrometer that will be used to build laboratory capacity and advance research into the treatment of HIV and Acquired Immune Deficiency Syndrome (AIDS)-related illnesses in sub-Saharan Africa. The University at Buffalo has the only pharmacy school in the State University of New York System and is an internationally recognized leader in HIV clinical pharmacology and therapeutics research.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
